Thus, other signaling pathways could be activated in osteosarcoma cells and counterbalance cell cycle inhibition observed in the presence of ICG-001, such as activation of cyclin D1 gene transcription by Jun/Fos or STAT3 factors [35]. This evidence concerns the gene JUN and osteosarcoma.